bpc-157 fda approval status pipeline is reviewing seven peptides this week, BPC-157, MOTS-c, and Epitalon among them. Committee meets Thursday and Friday, and the likely outcome is tighter restrictions on compounding pharmacies. Read past the headline The seven peptides being voted

It is thought to do this by stimulating human growth receptors in injured tissue

Cell 117 , 495502 (2004)

Allergy risk to cobalt or preservatives (rare) Energy improvement: 24-72 hours Reticulocyte response: 3-5 days Neurological improvement: Weeks to months Hematological normalization: 4-8 weeks Maximum nerve repair: Up to 1 year Injection site reactions (15-20%) Mild diarrhea (initial doses) Itching/eczema (cobalt sensitivity) Transient anxiety (overstimulation) Headache (usually resolves quickly) Serious reactions are extremely rare

Jimmy Santiago Baca reads poems and prose from his body of work, including A Glass of Water (2009), A Place to Stand (2002), Healing Earthquakes (2001), Martn & Meditations on the South Valley (1987), and C-Train (Dream Boy's Story) and Thirteen Mexicans: Poems (2002).

The average adult has approximately 5 million RBCs/L and 1417 g/dL hemoglobin (males) or 1215 g/dL (females), per StatPearls

BPC-157 was administered orally in drinking water at doses of 10 g/kg, 10 ng/kg, 0.16 g/ml, 0.16 ng/ml, and 12 ml daily